Accessibility Menu
 
Carl Zeiss Meditec Ag logo

Carl Zeiss Meditec Ag

(OTC) CZMWY

Current Price$28.25
Market Cap$2.42B
Since IPO (2008)+217%
5 Year-81%
1 Year-62%
1 Month-13%

Carl Zeiss Meditec Ag Financials at a Glance

Market Cap

$2.42B

Revenue (TTM)

$2.23B

Net Income (TTM)

$141.22M

EPS (TTM)

$1.79

P/E Ratio

15.45

Dividend

$0.65

Beta (Volatility)

1.07 (Average)

Price

$28.25

Volume

345

Open

$27.57

Previous Close

$27.70

Daily Range

$27.57 - $29.00

52-Week Range

$26.65 - $75.01

CZMWY News

No articles available.

CZMWY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Carl Zeiss Meditec Ag

Industry

Healthcare Equipment and Supplies

Employees

5,784

CEO

Maximilian Foerst

Headquarters

Jena, 07745, DE

CZMWY Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

13%

Net Income Margin

6%

Return on Equity

7%

Return on Capital

10%

Return on Assets

4%

Earnings Yield

6.47%

Dividend Yield

0.02%

Payout Ratio

37.19%

Stock Overview

Market Cap

$2.42B

Shares Outstanding

87.54M

Volume

345

Short Interest

0.00%

Avg. Volume

5.89K

Financials (TTM)

Gross Profit

$1.18B

Operating Income

$223.32M

EBITDA

$346.89M

Operating Cash Flow

$231.68M

Capital Expenditure

$43.49M

Free Cash Flow

$188.19M

Cash & ST Invst.

$27.27M

Total Debt

$132.46M

Carl Zeiss Meditec Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$627.54M

+8.3%

Gross Profit

$610.89M

+110.6%

Gross Margin

97.35%

N/A

Market Cap

$2.42B

N/A

Market Cap/Employee

$1.17M

N/A

Employees

2,066

N/A

Net Income

$51.81M

-14.7%

EBITDA

$207.48M

+520.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$105.19M

+21.2%

Accounts Receivable

$812.73M

+39.4%

Inventory

$496.98M

-7.3%

Long Term Debt

$108.32M

-14.5%

Short Term Debt

$67.97M

+151.1%

Return on Assets

4.08%

N/A

Return on Invested Capital

10.12%

N/A

Free Cash Flow

$179.50M

+376.0%

Operating Cash Flow

$198.61M

+4.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANSLFAnsell Limited
$22.74+5.54%
WLCGFWelcia Holdings Co., Ltd.
$16.41+0.00%
SNPHFSanten Pharmaceutical Co., Ltd.
$10.99+0.00%
FLMNYFielmann AG
$9.94+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.26-0.05%
TERNTerns Pharmaceuticals
$52.78+0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.83+0.03%
UGROUrban-gro
$13.11+0.87%

Questions About CZMWY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.